Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Laboratory confirmed shigellosis in Malagasy children

Domaine:

healthcare
Créateur:
LalPauDerZak
Éditeur:
Med
Hôte:
Background: Diarrheal diseases are a major public health problem in developing countries with high mortality and morbidity rates, especially among children. Shigella species is the leading cause of paediatric bacterial diarrhea and shigellosis data are very scarce in Madagascar.Methods: A 3 year retrospective study from January 2018 to December 2020, at the University Hospital Mother and Child Tsaralalàna laboratory was performed to assess the bacteriological and epidemiological characteristics of laboratory confirmed shigellosis cases.Results: During the study period, 298 stool samples were examined, of which 48 (16.1%) were positive for Shigella sp. The mean age of infected children was 29.7 months, predominantly in the 24-59 months age group. The infection was found mainly in male children (56.2%). Most isolates of Shigella sp showed resistance to co-trimoxazole and amoxicillin. All the strains were susceptible to third-generation cephalosporins. Of the isolated Shigella sp, 14 strains were tested for species identification and serotyping, twelve of which were Shigella flexneri and two were Shigella sonnei. The most frequent serotypes were S. flexneri 1b and 2a.Conclusions: This study found a Shigella sp positivity rate of 16.1%. This pathogen frequently infects infants age group. Bacteriology laboratory surveillance and a multicenter survey are essential to control the spread of drug-resistant Shigella and to monitor circulating strains and the burden of this disease. Awareness of water, hygiene and sanitation (WASH) and community water supply is also necessary to reduce this infection.

Visit

doi.org

Languages

MalagasyMalagasy, Merina

Similaires

LABORATORY-CONFIRMED MEDITERRANEAN SPOTTED FEVER IN A JAPANESE TRAVELER TO KENYAThe first laboratory-confirmed imported infections of SARS-CoV-2 in SudanThe effect of empirical and laboratory-confirmed tuberculosis on treatment outcomesTime series data of COVID-19 cases (rT-PCR-confirmed), hospitalisations (laboratory-confirmed), and hospital-associated deaths (laboratory confirmed) in South Africa, by imputed dates of symptom onset, from the start of the pandemic in March 2020 through April 2022.Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011–2018Estimating vaccine effectiveness in preventing laboratory‐confirmed influenza in outpatient settings in South Africa, 2015

LABORATORY-CONFIRMED MEDITERRANEAN SPOTTED FEVER IN A JAPANESE TRAVELER TO KENYA

A Japanese traveler returning from Kenya became ill, presenting with fever and a prominent, generali

The first laboratory-confirmed imported infections of SARS-CoV-2 in Sudan

Abstract Background The rapidly growing pan

The effect of empirical and laboratory-confirmed tuberculosis on treatment outcomes

Abstract The World Health Organization (WHO) criteria for diagnosing and treating Tuberculosis (TB)

Time series data of COVID-19 cases (rT-PCR-confirmed), hospitalisations (laboratory-confirmed), and hospital-associated deaths (laboratory confirmed) in South Africa, by imputed dates of symptom onset, from the start of the pandemic in March 2020 through April 2022.

Time series data of COVID-19 cases (rT-PCR-confirmed), hospitalisations (laboratory-confirm

Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011–2018

Background The 13-valent pneumococcal conjugate vaccine (PCV13) entered Cameroon’s childhood natio

Estimating vaccine effectiveness in preventing laboratory‐confirmed influenza in outpatient settings in South Africa, 2015

Trivalent seasonal influenza vaccine effectiveness during the 2015 season in South Africa was assess